Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Simone Hausmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9577-4225; OpenAlex author ID A5017183454; NIH RePORTER profile ID 15146378. Sources: OpenAlex.

Their work

Papers
8 (first author 4, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
30
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 grant · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 8

  1. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… Co-author DOI 10.1038/s41591-026-04234-8↗
  2. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… Co-author DOI 10.1038/s41591-024-03054-y↗
  3. SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. First author DOI 10.1016/j.ccell.2020.04.014↗
  4. Pathobiology of pancreatic cancer: implications on therapy. First author DOI 10.1586/14737140.2016.1129276↗
  5. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/nm.3952↗
  6. The role of inflammation in pancreatic cancer. Co-author DOI 10.1007/978-3-0348-0837-8_6↗
  7. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. First author DOI 10.1038/nrgastro.2012.115↗
  8. How fibrosis influences imaging and surgical decisions in pancreatic cancer. First author DOI 10.3389/fphys.2012.00389↗

Grants 1

  1. Mechanisms of translational output control in pancreatic cancer K99CA255936↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jorg H. Kleeff · 6 shared papers, 2012–2026 · strength 0.52
  2. Mert Erkan · 6 shared papers, 2012–2026 · strength 0.50
  3. Julien Sage · 4 shared papers, 2015–2026 · strength 0.46
  4. Pawel Karol Mazur · 4 shared papers, 2015–2026 · strength 0.46
  5. Iréne Esposito · 4 shared papers, 2015–2026 · strength 0.45
  6. Marija Trajkovic‐Arsic · 3 shared papers, 2015–2026 · strength 0.37
  7. Stephano S. Mello · 3 shared papers, 2015–2026 · strength 0.37
  8. Bence Sipos · 3 shared papers, 2015–2026 · strength 0.37
  9. Irina Heid · 3 shared papers, 2015–2026 · strength 0.37
  10. Stephan A. Hahn · 3 shared papers, 2015–2026 · strength 0.37
  11. Alexander Herner · 3 shared papers, 2015–2026 · strength 0.37
  12. Roland Michael Schmid · 3 shared papers, 2015–2026 · strength 0.37
  13. Jens Thomas Siveke · 3 shared papers, 2015–2026 · strength 0.37
  14. Elisabeth Heßmann · 3 shared papers, 2015–2026 · strength 0.37
  15. Laura D Attardi · 3 shared papers, 2015–2026 · strength 0.37
  16. Rickmer Braren · 3 shared papers, 2015–2026 · strength 0.37
  17. Matthias Wirth · 3 shared papers, 2015–2026 · strength 0.37
  18. Volker Ellenrieder · 3 shared papers, 2015–2026 · strength 0.37
  19. Tyler Jacks · 3 shared papers, 2015–2026 · strength 0.37
  20. Helmut Frieß · 3 shared papers, 2012–2014 · strength 0.12
  21. Christoph W. Michalski · 3 shared papers, 2012–2014 · strength 0.12
  22. Huamin Wang · 1 shared paper, 2020 · strength 0.08
  23. Michael P. Kim · 1 shared paper, 2020 · strength 0.08
  24. Anirban Maitra · 1 shared paper, 2020 · strength 0.08
  25. Zhentian Wang · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.